Emerging CAR T cell therapies: clinical landscape and patent technological routes (2020)
Picanço-Castro, Virgínia; Pereira, Cristiano Gonçalves; Swiech, Kamilla 
; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu; Porto, Geciane Silveira
Source: Human Vaccines & Immunotherapeutics. Unidades: FMRP, FCFRP, FEARP
Subjects: PATENTE, TECNOLOGIA, CÉLULAS, TESTES LABORATORIAIS, INOVAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, v. 16, n. 6, p. 1424–1433, 2020Tradução . . Disponível em: https://doi.org/10.1080/21645515.2019.1689744. Acesso em: 19 nov. 2024.APA
Picanço-Castro, V., Pereira, C. G., Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Porto, G. S. (2020). Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, 16( 6), 1424–1433. doi:10.1080/21645515.2019.1689744NLM
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1080/21645515.2019.1689744Vancouver
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1080/21645515.2019.1689744
